Search

COVID-19 causes significant thrombosis and coagulopathy, with elevated D-dimer a predictor of adverse outcome. The precise mechanism of this coagulopathy remains unclear; one hypothesis is that loss of angiotensin-converting enzyme 2 activity during viral endocytosis leads to pro-inflammatory angiotensin-II accumulation, loss of angiotensin-1-7 and subsequent vascular endothelial activation. We undertook a double-blind randomized, placebo-controlled experimental medicine study to assess the effect of TRV027, a synthetic angiotensin-1-7 analogue on D-dimer in 30 patients admitted to hospital with COVID-19. The study showed a similar rate of adverse events in TRV027 and control groups. There was a numerical decrease in D-dimer in the TRV027 group and increase in D-dimer in the placebo group; however, this did not reach statistical significance (P = .15). A Bayesian analysis demonstrated that there was a 92% probability that this change represented a true drug effect. [ABSTRACT FROM AUTHOR]

Background: Antiretroviral therapy (ART) has led to dramatic improvements in survival for people living with HIV, but is unable to cure infection, or induce viral control off therapy. Designing intervention trials with novel agents with the potential to confer a period of HIV remission without ART remains a key scientific and community goal. We detail the rationale, design, and outcomes of a randomised, placebo-controlled trial of two HIV-specific long-acting broadly neutralising antibodies (bNAbs): 3BNC117-LS and 10-1074-LS, which target CD4 binding site and V3 loop respectively, on post-treatment viral control.Methods: RIO is a randomised, placebo-controlled, double-blinded prospective phase II study. Eligible individuals will have started ART within 3 months of primary HIV infection and have viral sequences that appear to be sensitive to both bNAbs. It will randomise 72 eligible participants 1:1 to the following arms via a two-stage design. In Stage 1, arm A participants are given dual long-acting (LS-variants) bNAbs infusions, followed by intensively monitored Analytical Treatment Interruption (ATI) (n = 36); in arm B, participants receive placebo infusions followed by ATI. The primary endpoint will be time to viral rebound within 36 weeks after ATI. Upon viral rebound, the participant and researcher are unblinded. Participants in arm A recommence ART and complete the study. Participants in arm B are invited to restart ART and enroll into Stage 2 where they will receive open-label LS bNAbs, followed by a second ATI 24 weeks after. Secondary and exploratory endpoints include adverse events, time to undetectable viraemia after restarting ART, immunological markers, HIV proviral DNA, serum bNAb concentrations in blood, bNAb resistance at viral rebound, and quality of life measures.Discussion: The two-stage design was determined in collaboration with community involvement. This design allows all participants the option to receive bNAbs. It also tests the hypothesis that bNAbs may drive sustained HIV control beyond the duration of detectable bNAb concentrations. Community representatives were involved at all stages. This included the two-stage design, discussion on the criteria to restart ART, frequency of monitoring visits off ART, and reducing the risk of onward transmission to HIV-negative partners. It also included responding to the challenges of COVID-19.Trial Registration: The protocol is registered on Clinical.Trials: gov and EudraCT and has approval from UK Ethics and MHRA. [ABSTRACT FROM AUTHOR]

CD44 has been postulated as a cell surface coreceptor for augmenting receptor tyrosine kinase (RTK) signaling. However, how exactly CD44 triggers RTK-dependent signaling remained largely unclear. Here we report an unexpected mechanism by which the CD44s splice isoform is internalized into endosomes to attenuate EGFR degradation. We identify a CD44s-interacting small GTPase, Rab7A, and show that CD44s inhibits Rab7A-mediated EGFR trafficking to lysosomes and subsequent degradation. Importantly, CD44s levels correlate with EGFR signature and predict poor prognosis in glioblastomas. Because Rab7A facilitates trafficking of many RTKs to lysosomes, our findings identify CD44s as a Rab7A regulator to attenuate RTK degradation. [ABSTRACT FROM AUTHOR]

Summary Oncogenic mutations in two isocitrate dehydrogenase ( IDH )-encoding genes ( IDH1 and IDH2 ) have been identified in acute myelogenous leukemia, low-grade glioma, and secondary glioblastoma (GBM). Our in silico and wet-bench analyses indicate that non-mutated IDH1 mRNA and protein are commonly overexpressed in primary GBMs. We show that genetic and pharmacologic inactivation of IDH1 decreases GBM cell growth, promotes a more differentiated tumor cell state, increases apoptosis in response to targeted therapies, and prolongs the survival of animal subjects bearing patient-derived xenografts (PDXs). On a molecular level, diminished IDH1 activity results in reduced α-ketoglutarate (αKG) and NADPH production, paralleled by deficient carbon flux from glucose or acetate into lipids, exhaustion of reduced glutathione, increased levels of reactive oxygen species (ROS), and enhanced histone methylation and differentiation marker expression. These findings suggest that IDH1 upregulation represents a common metabolic adaptation by GBMs to support macromolecular synthesis, aggressive growth, and therapy resistance. [ABSTRACT FROM AUTHOR]

RNA interference (RNAi)-based gene regulation platforms have shown promise as a novel class of therapeutics for the precision treatment of cancer. Techniques in preclinical evaluation of RNAibased nanoconjugates have yet to allow for optimization of their gene regulatory activity.We have developed spherical nucleic acids (SNAs) as a blood--brain barrier-/blood--tumor barrier-penetrating nanoconjugate to deliver small interfering (si) and micro (mi)RNAs to intracranial glioblastoma (GBM) tumor sites. To identify high-activity SNA conjugates and to determine optimal SNA treatment regimens, we developed a reporter xenograft model to evaluate SNA efficacy in vivo. Engrafted tumors stably coexpress optical reporters for luciferase and a nearinfrared (NIR) fluorescent protein (iRFP670), with the latter fused to the DNA repair protein O6-methylguanine-DNA-methyltransferase (MGMT). Using noninvasive imaging of animal subjects bearing reporter-modified intracranial xenografts, we quantitatively assessed MGMT knockdown by SNAs composed of MGMT-targeting siRNA duplexes (siMGMT-SNAs). We show that systemic administration of siMGMT-SNAs via single tail vein injection is capable of robust intratumoral MGMT protein knockdown in vivo, with persistent and SNA dose-dependent MGMT silencing confirmed by Western blotting of tumor tissue ex vivo. Analyses of SNA biodistribution and pharmacokinetics revealed rapid intratumoral uptake and significant intratumoral retention that increased the antitumor activity of coad ministered temozolomide (TMZ). Our study demonstrates that dual noninvasive bioluminescence and NIR fluorescence imaging of cancer xenograft models represents a powerful in vivo strategy to identify RNAi-based nanotherapeutics with potent gene silencing activity and will inform additional preclinical and clinical investigations of these constructs. [ABSTRACT FROM AUTHOR]

Therapy resistance is a major limitation to the successful treatment of cancer. Here, we identify Bcl2-like 13 (Bcl2L13), an atypical member of the Bcl-2 family, as a therapy susceptibility gene with elevated expression in solid and blood cancers, including glioblastoma (GBM). We demonstrate that mitochondria-associated Bcl2L13 inhibits apoptosis induced by a wide spectrum of chemo- and targeted therapies upstream of Bcl2-associated X protein activation and mitochondrial outer membrane permeabilization in vitro and promotes GBM tumor growth in vivo. Mechanistically, Bcl2L13 binds to proapoptotic ceramide synthases 2 (CerS2) and 6 (CerS6) via a unique C-terminal 250-aa sequence located between its Bcl-2 homology and membrane anchor domains and blocks homo- and heteromeric CerS2/6 complex formation and activity. Correspondingly, CerS2/6 activity and Bcl2L13 abundance are inversely correlated in GBM tumors. Thus, our genetic and functional studies identify Bcl2L13 as a regulator of therapy susceptibility and point to the Bcl2L13-CerS axis as a promising target to enhance responses of therapy-refractory cancers toward conventional and targeted regimens currently in clinical use. [ABSTRACT FROM AUTHOR]

The purpose of the present study was to examine how relationship duration was related to conflict strategies and levels of intimacy in romantic relationships and how that might vary by gender. Participants completed self-report measures to assess perceived levels of reciprocal intimacy and reported uses of positive and negative conflict strategies. Results found an inverted U-shaped pattern for negative conflict strategies and a linear increase in levels of intimacy with duration. No differences were found for positive conflict strategies with duration. Gender differences were found for levels of intimacy, with women reporting higher levels of relationship intimacy as compared to men regardless of relationship duration; but, no gender differences were found for either positive or negative conflict strategies. Future research in this area should replicate these findings to further support the importance of romantic relationship development in examining relationship qualities such as conflict strategies and intimacy. [ABSTRACT FROM AUTHOR]

Genome-wide mutagenesis was performed in mice to identify candidate genes for male infertility, for which the predominant causes remain idiopathic. Mice were mutagenized using N-ethyl- N-nitrosourea (ENU), bred, and screened for phenotypes associated with the male urogenital system. Fifteen heritable lines were isolated and chromosomal loci were assigned using low-density genome-wide SNP arrays. Ten of the 15 lines were pursued further using higher-resolution SNP analysis to narrow the candidate gene regions. Exon sequencing of candidate genes identified mutations in mice with cystic kidneys ( Bicc1), cryptorchidism ( Rxfp2), restricted germ cell deficiency ( Plk4), and severe germ cell deficiency ( Prdm9). In two other lines with severe hypogonadism, candidate sequencing failed to identify mutations, suggesting defects in genes with previously undocumented roles in gonadal function. These genomic intervals were sequenced in their entirety and a candidate mutation was identified in SnrpE in one of the two lines. The line harboring the SnrpE variant retains substantial spermatogenesis despite small testis size, an unusual phenotype. In addition to the reproductive defects, heritable phenotypes were observed in mice with ataxia ( Myo5a), tremors ( Pmp22), growth retardation (unknown gene), and hydrocephalus (unknown gene). These results demonstrate that the ENU screen is an effective tool for identifying potential causes of male infertility. [ABSTRACT FROM AUTHOR]

Using genome-wide mutagenesis with N-ethyl- N-nitrosourea (ENU), a mouse mutant with cryptorchidism was identified. Genome mapping and exon sequencing identified a novel missense mutation (D294G) in Relaxin/insulin-like family peptide receptor 2 ( Rxfp2). The mutation impaired testicular descent and resulted in decreased testis weight in Rxfp2 mice compared to Rxfp2 and Rxfp2 mice. Testicular histology of the Rxfp2 mice revealed spermatogenic defects ranging from germ cell loss to tubules with Sertoli-cell-only features. Genetic complementation analysis using a loss-of-function allele ( Rxfp2) confirmed causality of the D294G mutation. Specifically, mice with one of each mutant allele ( Rxfp2) exhibited decreased testis weight and failure of the testes to descend compared to their Rxfp2 littermates. Total and cell-surface expression of mouse RXFP2 protein and intracellular cAMP accumulation were measured. Total expression of the D294G protein was minimally reduced compared to wild-type, but cell-surface expression was markedly decreased. When analyzed for cAMP accumulation, the EC50 was similar for cells transfected with wild-type and mutant RXFP2 receptor. However, the maximum cAMP response that the mutant receptor reached was greatly reduced compared to the wild-type receptor. In silico modeling of leucine rich repeats (LRRs) 7-9 indicated that aspartic acid 294 is located within the β-pleated sheet of LRR8. We thus postulate that mutation of D294 results in protein misfolding and aberrant trafficking. The ENU-induced D294G mutation underscores the role of the INSL3/RXFP2-mediated pathway in testicular descent and expands the repertoire of mutations known to affect receptor trafficking and function. [ABSTRACT FROM AUTHOR]

Deals with devising a model for compliance at all relationship levels of a fund company. Guide which could be helpful for fund companies to assess their readiness for the U.S. Securities and Exchange Commission examination; Range of capabilities which must be present and demonstrable in the due diligence process; Component which could serve as a total network of resources to support the fund company's goal of compliance.

Sox3 is expressed in developing gonads and in the brain. Evolutionary evidence suggests that the X-chromosomal Sox3 gene may be the ancestral precursor of Sry, a sex-determining gene, and Sox3 has been proposed to play a role in sex determination. However, patients with mutations in SOX3 exhibit normal gonadal determination but are mentally retarded and have short stature secondary to growth hormone (GH) deficiency. We used Cre-LoxP targeted mutagenesis to delete Sox3 from mice. Null mice of both sexes had no overt behavioral deficits and exhibited normal GH gene expression. Low body weight was observed for some mice; overgrowth and misalignment of the front teeth was observed consistently. Female Sox3 null mice (-/-) developed ovaries but had excess follicular atresia, ovulation of defective oocytes, and severely reduced fertility. Pituitary (luteinizing hormone and follicle-stimulating hormone) and uterine functions were normal in females. Hemizygous male null mice (-/Y) developed testes but were hypogonadal. Testis weight was reduced by 42%, and there was extensive Sertoli cell vacuolization, loss of germ cells, reduced sperm counts, and disruption of the seminiferous tubules. We conclude that Sox3 is not required for gonadal determination but is important for normal oocyte development and male testis differentiation and gametogenesis. [ABSTRACT FROM AUTHOR]

It is now well established that gold, in the form of oxide-supported microparticles or even as conventional macroelectrodes, displays inexplicably high catalytic activity for some reactions. In the present work, gold surfaces were superactivated by a combination of thermal and cathodic pretreatment and such electrodes in base yielded up to five distinct, and quite marked, premonolayer oxidation responses within the double layer region, over the range 0.0–1.0 V (RHE). As outlined in earlier publications, such unusual behaviour is important from an electrocatalytic (and heterogeneous catalysis) viewpoint. A new mode of active site adsorption, involving highly localized electron transfer from active surface atoms to either the external circuit (in electrocatalysis) or an adsorbing reactant (in heterogeneous catalysis), is proposed. Such localized (active site) adsorption, which is based on surface quantum confinement effects, is virtually independent of (or only indirectly related to) the electronic properties of the bulk metal. [ABSTRACT FROM AUTHOR]

Severe thermal pretreatment of gold wire electrodes in an inert gas atmosphere resulted in the appearance of dramatic premonolayer oxidation responses, which in some instances commenced at 0.25 V (RHE), for the resulting active gold electrodes in aqueous acid media. Similar behaviour was reported earlier for platinum and gold activated by cathodic pretreatment in acid solution; these active noble metal surfaces are evidently more susceptible to oxidation than bulk copper. Such behaviour was attributed to the effect of surface disorder; many of the metal atoms at the interface are assumed to be in a very active, metastable state possessing quite low lattice stabilization energy. Premonolayer oxidation responses are again correlated with electrocatalytic behaviour and the existence of unusual chemisorption behaviour for molecules reacting at highly active states of metals is outlined. [ABSTRACT FROM AUTHOR]

The present work is a continuation of an earlier investigation of the effect of severe thermal pretreatment on the redox properties of platinum electrodes in aqueous media. The most interesting observation was that raising the solution temperature to ca. 75 °C resulted in a dramatic anodic response in the positive sweep at ca. 0.25 V (RHE). Such behaviour was noted earlier at room temperature but only when the thermally pretreated sample was further activated by cathodic polarization. This transition at 0.25 V was partially reversed on the negative sweep, but the cathodic process involved was subject to severe inhibition. There is independent evidence for similar behaviour for gold in aqueous acid solution. The relevance of the present results to the operation of fuel cell anodes is outlined. [ABSTRACT FROM AUTHOR]

The article offers information on the role of the fund administrator as chief compliance officer (CCO). It is believed that an expert CCO often takes a better offer from a fund company and is equipped with relevant experience and an ability to be flexible as it assists the company to comply with the U.S. Securities and Exchange Commission (SEC) rules. Cited are the benefits of hiring an outside CCO and compliance provider, including the elimination of conflict of interest within the organization and leveraging of best practices.